BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 27261903)

  • 1. Women with Cirrhosis: Prevalence, Natural History, and Management.
    Giard JM; Terrault NA
    Gastroenterol Clin North Am; 2016 Jun; 45(2):345-58. PubMed ID: 27261903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study.
    Vaz J; Eriksson B; Strömberg U; Buchebner D; Midlöv P
    BMC Gastroenterol; 2020 Apr; 20(1):84. PubMed ID: 32245414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.
    Yang JD; Mohamed HA; Cvinar JL; Gores GJ; Roberts LR; Kim WR
    Am J Gastroenterol; 2016 Nov; 111(11):1573-1580. PubMed ID: 27527741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults.
    Marengo A; Jouness RI; Bugianesi E
    Clin Liver Dis; 2016 May; 20(2):313-24. PubMed ID: 27063271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperlipidemia and Nonalcoholic Steatohepatitis Predispose to Hepatocellular Carcinoma Development Without Cirrhosis.
    Phan J; Ng V; Sheinbaum A; French S; Choi G; El Kabany M; Durazo F; Saab S; Tong M; Busuttil R; Han SH
    J Clin Gastroenterol; 2019 Apr; 53(4):309-313. PubMed ID: 29912756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Changing Global Epidemiology of Hepatocellular Carcinoma.
    Caines A; Selim R; Salgia R
    Clin Liver Dis; 2020 Nov; 24(4):535-547. PubMed ID: 33012444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efforts to define the natural history of chronic hepatitis C continue.
    Ghany MG; Seeff LB
    Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1190-2. PubMed ID: 17045209
    [No Abstract]   [Full Text] [Related]  

  • 8. NASH and HCC.
    Page JM; Harrison SA
    Clin Liver Dis; 2009 Nov; 13(4):631-47. PubMed ID: 19818310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and risk factors of hepatocellular carcinoma in patients with primary biliary cirrhosis.
    Macaron C; Hanouneh IA; Zein NN
    Hepatology; 2010 Dec; 52(6):2239; author reply 2239-40. PubMed ID: 21105115
    [No Abstract]   [Full Text] [Related]  

  • 10. Incidence, prevalence and mortality of chronic liver diseases in Sweden between 2005 and 2019.
    Nasr P; von Seth E; Mayerhofer R; Ndegwa N; Ludvigsson JF; Hagström H
    Eur J Epidemiol; 2023 Sep; 38(9):973-984. PubMed ID: 37490175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Implications of Concomitant Alcohol Use, Obesity, and Viral Hepatitis.
    Serfaty L
    Gastroenterology; 2016 Jun; 150(8):1718-22. PubMed ID: 26873400
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.
    Younossi Z; Stepanova M; Ong JP; Jacobson IM; Bugianesi E; Duseja A; Eguchi Y; Wong VW; Negro F; Yilmaz Y; Romero-Gomez M; George J; Ahmed A; Wong R; Younossi I; Ziayee M; Afendy A;
    Clin Gastroenterol Hepatol; 2019 Mar; 17(4):748-755.e3. PubMed ID: 29908364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma: A Growing Epidemic?
    Yopp AC; Choti MA
    Dig Dis; 2015 Sep; 33(5):642-7. PubMed ID: 26398208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effects of Hepatic Steatosis on the Natural History of HBV Infection.
    Suliman I; Abdelgelil N; Kassamali F; Hassanein TI
    Clin Liver Dis; 2019 Aug; 23(3):433-450. PubMed ID: 31266618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter to the Editor: Hepatocellular Carcinoma Risk in Patients With Nonalcoholic Steatohepatitis Cirrhosis and Diabetes: Insufficient for Individual Management.
    Feng Z; Rong P; Wang W
    Hepatology; 2020 Jul; 72(1):361-362. PubMed ID: 31903611
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of nonalcoholic fatty liver disease and liver cancer.
    Schulz PO; Ferreira FG; Nascimento Mde F; Vieira A; Ribeiro MA; David AI; Szutan LA
    World J Gastroenterol; 2015 Jan; 21(3):913-8. PubMed ID: 25624725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.
    Beste LA; Leipertz SL; Green PK; Dominitz JA; Ross D; Ioannou GN
    Gastroenterology; 2015 Nov; 149(6):1471-1482.e5; quiz e17-8. PubMed ID: 26255044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic steatohepatitis-related liver cirrhosis is increasing in China: a ten-year retrospective study.
    Xiong J; Wang J; Huang J; Sun W; Wang J; Chen D
    Clinics (Sao Paulo); 2015 Aug; 70(8):563-8. PubMed ID: 26247669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten years of hospital admissions for liver cirrhosis in Portugal.
    Silva MJ; Rosa MV; Nogueira PJ; Calinas F
    Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1320-6. PubMed ID: 26275086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma: an emerging problem with hepatitis C.
    Jeffers L
    J Natl Med Assoc; 2000 Aug; 92(8):369-71. PubMed ID: 10992680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.